What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001936953
Total reported value
$7.9B
$7.9B
992 檔
7.0%
As reported in its official Q1 2024 Form 13F filing, Bleakley Financial Group, LLC's tracked investment portfolio stood at $7.9B with 992 total positions.
During Q1 2024, Bleakley Financial Group, LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
Showing top 200 holdings (of 992 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | VV | Vanguard Large-cap ETF | ETF-Other | 4.04% | -0.18% | +3.23% | |
| 2 | CEF | Sprott Physical Gold And Sil | Stock-Other | 3.49% | -0.97% | -1.52% | |
| 3 | AAPL | Apple Inc | Stock-Tech | 3.07% | +0.05% | +1.07% | |
| 4 | MSFT | Microsoft CORP | Stock-Tech | 2.77% | -0.26% | +5.30% | |
| 5 | VTV | Vanguard Value ETF | ETF-Other | 2.64% | -0.17% | +1.38% | |
| 6 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 2.55% | -0.03% | -0.84% | |
| 7 | VO | Vanguard Mid-cap ETF | ETF-Other | 2.54% | -0.14% | +3.83% | |
| 8 | VTEB | Vanguard Tax-exempt Bond ETF | ETF-Other | 2.11% | -0.15% | +3.87% | |
| 9 | PHYS | Sprott Physical Gold Trust | Stock-Other | 1.92% | -0.37% | -1.11% | |
| 10 | SGOV | Ishares 0-3 Month Treasury B | ETF-Gov Bonds | 1.81% | -0.19% | +10.18% | |
| 11 | SHY | Ishares 1-3 Year Treasury Bo | ETF-Gov Bonds | 1.69% | -0.23% | -0.19% | |
| 12 | VT | Vanguard Tot World Stk ETF | ETF-Other | 1.56% | -0.12% | +3.20% | |
| 13 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 1.47% | +0.07% | +5.41% | |
| 14 | NVDA | Nvidia CORP | Stock-Tech | 1.31% | +0.13% | -0.08% | |
| 15 | QQQ | Invesco Qqq Trust Series 1 | ETF-Tech | 1.15% | +0.20% | +1.48% | |
| 16 | LLY | Eli Lilly & Co | Stock-Healthcare | 1.09% | +0.14% | +4.42% | |
| 17 | VTIP | Vanguard Short-term Tips | ETF-Other | 0.91% | -0.05% | +8.51% | |
| 18 | SLV | Ishares Silver Trust | ETF-Commodities | 0.91% | -0.18% | -11.91% | |
| 19 | VOO | Vanguard S&p 500 ETF | ETF-Large Cap & Growth | 0.86% | -0.01% | +1.22% | |
| 20 | META | Meta Platforms Inc-class A | Stock-Comm Services | 0.85% | -0.16% | +6.20% | |
| 21 | SCHG | Schwab US Large-cap Growth | ETF-Other | 0.79% | -0.04% | -3.58% | |
| 22 | GOOG | Alphabet Inc-cl C | Stock-Comm Services | 0.74% | +0.02% | +3.05% | |
| 23 | GLD | Spdr Gold Shares | ETF-Commodities | 0.68% | -0.26% | +1.85% | |
| 24 | BRK-B | Berkshire Hathaway Inc-cl B | Stock-Other | 0.66% | -0.06% | -8.43% | |
| 25 | ABBV | Abbvie Inc | Stock-Healthcare | 0.62% | +0.05% | +5.53% | |
| 26 | GOOGL | Alphabet Inc-cl A | Stock-Comm Services | 0.62% | +0.14% | +4.03% | |
| 27 | BSX | Boston Scientific CORP | Stock-Healthcare | 0.57% | — | +6.11% | |
| 28 | NVO | Novo-nordisk A/s-spons Adr | Stock-Healthcare | 0.57% | -0.01% | +22.78% | |
| 29 | AVGO | Broadcom Inc | Stock-Tech | 0.56% | +0.06% | +0.95% | |
| 30 | STPZ | Pimco 1-5 Year US Tips Index | ETF-Large Cap & Growth | 0.56% | -0.05% | -12.80% | |
| 31 | IJR | Ishares Core S&p Small-cap E | ETF-Small Cap | 0.55% | -0.08% | +4.67% | |
| 32 | IVV | Ishares Core S&p 500 ETF | ETF-Large Cap & Growth | 0.53% | +0.05% | -0.79% | |
| 33 | JNJ | Johnson & Johnson | Stock-Healthcare | 0.51% | -0.04% | -0.09% | |
| 34 | JPM | Jpmorgan Chase & Co | Stock-Financials | 0.50% | -0.03% | +1.37% | |
| 35 | BIL | Ss Spdr Bb 1-3m T-bill ETF | ETF-Gov Bonds | 0.48% | +0.02% | -49.60% | |
| 36 | SCHM | Schwab US Mid Cap ETF | ETF-Other | 0.47% | +0.01% | +2.00% | |
| 37 | HD | Home Depot Inc | Stock-Consumer Disc | 0.46% | -0.03% | +5.49% | |
| 38 | SYK | Stryker CORP | Stock-Healthcare | 0.45% | -0.03% | +5.50% | |
| 39 | IWD | Ishares Russell 1000 Value E | ETF-Other | 0.43% | +0.01% | -21.68% | |
| 40 | CGXU | Cap Group Intl Focus | ETF-Other | 0.43% | -0.02% | +3.06% | |
| 41 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 0.42% | — | -19.14% | |
| 42 | HCA | Hca Healthcare Inc | Stock-Healthcare | 0.41% | — | +25.53% | |
| 43 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 0.40% | — | +60.19% | |
| 44 | COR | Cencora Inc | Stock-Healthcare | 0.39% | -0.04% | +5.37% | |
| 45 | DIS | Walt Disney Co/the | Stock-Comm Services | 0.39% | -0.02% | +5.32% | |
| 46 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 0.39% | +0.13% | -39.74% | |
| 47 | PG | Procter & Gamble Co/the | Stock-Consumer Staples | 0.38% | -0.03% | +2.69% | |
| 48 | IWB | Ishares Russell 1000 ETF | ETF-Other | 0.38% | -0.01% | +1.78% | |
| 49 | V | Visa Inc-class A Shares | Stock-Financials | 0.38% | — | +7.47% | |
| 50 | ELV | Elevance Health Inc | Stock-Healthcare | 0.36% | — | +445.27% |
According to official SEC Form 13F filings, Bleakley Financial Group, LLC reported a total U.S. public equity portfolio value of $7.9B across 992 disclosed positions in Q1 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including VV, CEF, AAPL) accounted for 7.0% of total reported equity market value during Q1 2024.
During Q1 2024, Bleakley Financial Group, LLC's top holdings by market value included VV (4.0%)、CEF (3.5%)、AAPL (3.1%). The largest single position, VV, represented 4.0% of total portfolio value.
In Q1 2024, Bleakley Financial Group, LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.